After 15 years of providing cutting-edge content on pharma technology and manufacturing, in-PharmaTechnologist.com will soon be merging into Outsourcing-Pharma.com. From March 30, 2020, news and analysis on the manufacture of small molecules, as well as their clinical and commercial development, will therefore be delivered by Outsourcing-Pharma.com.
All your favorite articles from in-PharmaTechnologist.com will automatically move to Outsourcing-Pharma.com, which means all your bookmarks will remain intact.
Likewise any e-newsletter subscriptions you may have to in-PharmaTechnologist.com will automatically be transferred to Outsourcing-Pharma.com from March 30, unless you are already an existing subscriber to the latter website.
Note that news and analysis on the entire lifecycle of large molecule drugs, from clinical to commercial development and the manufacturing process, will now be delivered by our sister site, BioPharma-Reporter.com.
Once the change is complete from March 30, you will be able to find out more details about the update coverage areas of both websites through their respective About Us sections, which you can find here for Outsourcing-Pharma and BioPharma-Reporter.
We would like to take this opportunity to thank you for your ongoing loyalty and we look forward to continuing to provide you with the pharma industry news and analysis that informs your business growth.